Advanced Search

 

Study ID Status Title Patient Level Data
RH01418 Completed A Pharmacokinetic Evaluation of Two Nicotine Patches in Smokers
RH01426 Completed A Proof of Concept Study to Evaluate the Efficacy of an Occlusion Based Dentifrice in the Relief of Dentinal Hypersensitivity
RH01561 Completed Clinical study to evaluate the efficacy of chlorhexidine mouthwashes
RH01589 Completed A Study to Evaluate Relief of Provoked Acute Craving by Nicotine Mouth Film and Nicotine Lozenge
RH01591 Completed A Proof of Concept Study to Evaluate the Efficacy of an Occlusion Based Dentifrice in the Relief of Dentinal Hypersensitivity
RH01619 Completed A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Study to Assess the Efficacy of Once-Daily Fluticasone Propionate Aqueous Nasal Spray 200mcg for 14 Days on Ocular Symptoms Associated with Seasonal Allergic Rhinitis
RH01685 Completed A Clinical Study Investigating the Efficacy of a Dentifrice in Providing Long Term Relief from Dentinal Hypersensitivity
RH01705 Completed A pharmacokinetic study comparing two nicotine gum formulations in a single dose design
RH01899 Completed The effect of a nutritional supplement on post prandial glucose and lipids in an adult population
RH01948 Completed Contac Nasal Spray Questionnaire
RHS00691 Completed Meta-analysis of the efficacy of ranitidine 75mg and ranitidine 150mg versus placebo on the reduction of severity or prevention of meal-induced heartburn
ROF102100 Completed A randomised, double blind, placebo-controlled, parallel group study to investigate the safety and efficacy of controlled-release ropinirole (CR) (1-24 mg) administered once daily for 12 weeks in subjects with fibromyalgia Study Listed on ClinicalStudyDataRequest.com
ROP105323 Completed A Randomised, Double-Blind, Double-Dummy, Parallel Group Comparison of 24 Weeks of Treatment with Ropinirole Immediate Release Tablets (REQUIP IR) or Ropinirole Prolonged Release Tablets (SK&F-101468) in Advanced Stage Parkinson’s Disease Subjects who are not Adequately Controlled on L-dopa.
ROP106064 Completed Clinical Evaluation of Ropinirole PR/XR Tablets in Monotherapy for Parkinson's Disease - an Open-Label, Uncontrolled Study -
ROP109087 Completed An open label, repeat dose, dose escalation study conducted in Parkinson's Disease patients to characterize the pharmacokinetics and effect of food on ropinirole prolonged release (PR/CR) 12mg tablets. Study Listed on ClinicalStudyDataRequest.com
ROR104836 Completed A parallel group study to evaluate the efficacy and safety of ropinirole for 26 weeks and to further evaluate the incidence of augmentation and rebound for a further 40 weeks open-label extension treatment period in subjects suffering from moderate to severe Restless Legs Syndrome. Study Listed on ClinicalStudyDataRequest.com
ROR106470 Completed An open label, repeat dose, dose escalation study conducted in RLS patients to characterize pharmacokinetics and food effect of ropinirole controlled release for RLS
ROTA-Meta-Analysis-201212 Completed Integrated safety summary of GSK Biologicals’ HRV vaccine (Rotarix™)
ROX104805 Completed A 4-Week, Randomized, Double-Blind, Cohort Study to Evaluate the Safety and Tolerability of Converting from Ropinirole Immediate Release (IR) to Ropinirole Extended Release (XR) Formulation in Patients with Restless Legs Syndrome (RLS) Study Listed on ClinicalStudyDataRequest.com
RRL103628 Completed An Open-Label, Parallel-Group, Repeat-Dose Study to Investigate the Effects of End Stage Renal Disease and Haemodialysis on the Pharmacokinetics of Ropinirole (Study RRL103628) Study Listed on ClinicalStudyDataRequest.com
RRL103660 Completed A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients with Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep Study Listed on ClinicalStudyDataRequest.com
RRL106721 Completed A multicenter 3:1-randomized placebo-controlled double-blind Phase IIIb study on the effects of Ropinirole on mood/(subclinical) depression in the therapy of patients with moderate to severe idiopathic RLS in Germany
RXP110908 Completed Study RXP110908, a polysomnography study of GSK1838262 (XP13512) extended release tablets versus placebo in the treatment of Restless Legs Syndrome (RLS) and associated sleep disturbance
S2110367 Completed A Randomized, Open Label Study to Evaluate the Oral Tolerability of a Nicotine Prototype
S2111378 Completed A Pilot Study to Evaluate Relief of Provoked Acute Craving by Nicotine Mouth Strip, Nicorette ® Nicotine Lozenge and Gum

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.